Glossary for Adult Congenital Heart Disease, P—P |
- palliation, palliative operation
- A procedure carried out for the purpose of relieving symptoms
or ameliorating some
of the adverse effects
of an anomaly, which does not address the
fundamental anatomic/physiologic disturbance.
Contrasts with "repair" or "reparative operation."
|
- PAPVC
- Partial anomalous pulmonary venous connection. See also
anomalous pulmonary
venous connection.
|
- parachute mitral valve
- A mitral valve abnormality
in which all chordae tendineae of
the mitral valve, which may be shortened
and thickened, insert in a single, abnormal
papillary muscle, usually causing mitral stenosis.
The parachute mitral valve may be part of the
Shone complex. See also
Shone complex.
|
- partial A-V septal defect
- See
atrio-ventricular septal defect.
|
- patent ductus arteriosus (PDA)
- A ductus that fails to undergo normal
closure in the early post-natal period.
syn. persistently patent ductus arteriosus,
persistent arterial duct.
|
- patent foramen ovale (PFO)
- Failure of anatomic fusion of the valve of the foramen ovale with the limbus of the fossa
ovalis that normally occurs when left atrial pressure
exceeds right atrial pressure after birth. There is no structural
deficiency of tissue of the atrial septum. The foramen is functionally
closed as long as left atrial pressure exceeds right atrial pressure, but
can reopen if right atrial pressure rises. PFO is found in up to 35%
of the adult population in pathological studies. The lower and variable
prevalence reported in clinical series depends on the techniques used to
find it. syn. probe-patent foramen ovale, PFO.
|
- pentalogy of Fallot
- Tetralogy of Fallot with, in addition, an ASD or PFO.
See also tetralogy of Fallot.
|
- perimembranous VSD
- See ventricular septal defect.
|
- persistent left superior vena cava (LSVC)
- Persistence of the left anterior cardinal vein (which normally obliterates
during embryogenesis) results in persistent left superior vena cava.
LSVC drains via the coronary sinus to the right atrium in more than 90%
of patients; rarely, it may directly drain to the left atrium in association
with other congenital heart defects (e.g., isomerism).
Its prevalence is up to 0.5% in the general population, and higher in patients with
congenital heart disease.
|
- PFO
- See patent foramen ovale.
|
- phlebotomy
- A palliative procedure involving withdrawal
of whole blood (usually in up to 500 mL increments) which
may be offered to patients with cyanotic CHD and secondary
erythrocytosis who are experiencing hyperviscosity symptoms.
Concomitant volume replacement is usually indicated.
|
- pink tetralogy of Fallot
- See tetralogy of Fallot.
|
- polycythemia vera
- A neoplastic transformation of all blood
cell lines (erythrocyte, leukocyte, and platelet)
associated with increased numbers of cells in the
peripheral blood. Contrast with secondary erythrocytosis
as seen in cyanotic heart disease.
See also erythrocytosis.
|
- polysplenia syndrome
- See
isomerism, and right isomerism.
|
- Potts shunt
- A palliative operation
for the purpose of increasing pulmonary blood flow,
hence systemic oxygen saturation. The procedure involves creating a small
communication between a pulmonary artery and the ipsilateral descending thoracic
aorta. Often complicated by the development of pulmonary vascular obstructive
disease if too large, or acquired stenosis or atresia of the pulmonary
artery if distortion occurs. (Potts WJ et al. Anastomosis of aorta to pulmonary
artery: certain types of congenital heart disease. JAMA 1946;132:627-631.)
|
- PPH
- Primary pulmonary hypertension. See also pulmonary hypertension.
|
- probe-patent foramen ovale
- See patent foramen ovale.
|
- protein-losing enteropathy (PLE)
- A complication seen following the Fontan operation in which protein is lost
via the gut, resulting in ascites, peripheral oedema, pleural and
pericardial effusions. It is of unknown cause, though exacerbated by
high systemic venous pressure. If serum protein and albumin are low,
increased alpha-1 antitrypsin in the stool supports the diagnosis of PLE.
|
- protrusio acetabulae
- Abnormal displacement of the head of the femur within the acetabulum.
A radiological finding useful in the diagnosis of Marfan syndrome.
|
- pseudotruncus arteriosus
- Pulmonary atresia with a VSD, biventricular aorta,
and pulmonary blood flow provided by systemic to pulmonary
collaterals. This anatomic arrangement
had previously been called "truncus arteriosus type IV"
but is morphogenetically a different lesion from truncus
arteriosus. In pseudotruncus, the single vessel arising
from the ventricles is an aorta with an aortic valve, not
a truncus with a truncal valve, and pulmonary blood flow
derives from aorto-pulmonary collateral arteries, not
from anomalously connected true pulmonary arteries.
|
- pulmonary artery banding
- Surgically created stenosis of the main
pulmonary artery performed as a palliative procedure
to protect the lungs against high blood flow and
pressure when definitive correction of the underlying
anomaly is not immediately advisable, e.g. in the setting of a non-restrictive VSD.
|
- pulmonary artery sling
- Anomalous origin of the left pulmonary
artery from the right pulmonary artery,
such that it loops around the trachea.
It may be associated with complete
cartilaginous rings in the distal trachea
and tracheal stenosis. It may occur as an
isolated entity or in association with other
congenital heart defects.
|
- pulmonary atresia
- An imperforate pulmonary valve.
When associated with a VSD (variant of tetralogy of Fallot),
pulmonary blood flow arises from aorto-pulmonary collaterals,
and systemic venous return exits the right heart via the
VSD. When associated with intact interventricular septum,
pulmonary artery blood supply is via a patent ductus arteriosus,
and systemic venous return exits the right heart via an obligatory ASD.
|
- pulmonary hypertension
- Elevated pulmonary arterial pressure.
A common method to define the severity of pulmonary hypertension
is the pulmonary/aortic systolic pressure ratio:
-
| Severity |
Ratio |
| mild |
>0.3, <0.6 |
| moderate |
>0.6, <0.9 |
| severe |
>0.9 (Eisenmenger syndrome). |
|
| |
| |
| |
| |
Glossary prepared by Jack M. Colman, MD, Toronto Congenital Cardiac Centre for Adults; Erwin N. Oechslin, MD, University Hospital, Zurich, Switzerland; and Dylan A. Taylor, MD, University of Alberta Hospital. Used with permission. |
|